维普中文期刊产品整合服务
21篇 您的检索式:作者名="Musuraca G"
    题名 作者 年代 出处 被引量
1Fludarabine-Containing Chemotherapy as Frontline Treatment of Nongastrointestinal Mucosa-Associated Lymphoid Tissue Lymphoma显示文摘Zinzani PL Stefoni V Musuraca G 2004Cancer2004,100,10:1
2Phase IItrial of proteasome inhibitor bortezomib in patients withrelapsed or refractory cutaneous T-cell lymphoma显示文摘ZINZANI P L MUSURACA G TANI M 2007JClin Oncol2007,25,:1
3Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma显示文摘Alinari L Musuraca G Tani M 0,,10:1
4producing T cells: new link between infections, IL-17/IL-10 double- and acute myeloid leukemia显示文摘Musuraca G De Matteis S Napolitano R 2015J Transl Med2015,13,:1
5Fludarabine - containing chemotherapy as frontline treatment of nongastrointestinal mucosa - associated lymphoid tissue lymphoma 显示文摘Zinzani PL Stefoni V Musuraca G 2004Cancer2004,100,10:1
6Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma显示文摘Zinzani PL Musuraca G Alinari L 2012Clin Lymph Myeloma2012,7,4:1
7Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma 显示文摘Zinzani PL Musuraca G Alinari L 2007Clin Lymphoma Myeloma2007,7,4:1
8Electrocardiographic abnormalities mimicking myocardial infarctioh in a patient with intracranial hemorrhage: A possible pitfall for prehospital thrombolysis显示文摘Musuraca G Imperadore F Cemin C 2006J Cardiovasc Med2006,7,:1
9Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma显示文摘 Stefoni V Musuraca G 2004Cancer2004,100,:1
10Thrombolytic treatment of acute myocardial infarction in lhe presence of ventricular paced rhythm 显示文摘lmperadore F Musuraca G Terraneo C 2008Minerva Cardioangiol2008,56,:1
11Phase Ⅱ trial of protea- some inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma 显示文摘Zinzani PL Musuraca G Tani M 2007J Clin Oncol2007,25,27:1
12Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma显示文摘Zinzani PL Musuraca G Alinari L 2007Clin Lymph Myeloma2007,7,4:1
13PhaseⅡtrial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma显示文摘Zinzani PL Musuraca G Tani M 2007J Clin Oncol2007,25,27:1
14Phase II of proteasome inhibitor bortezomib in patients with relapsed or refractory cuta- neous T - cell lymphoma 显示文摘Zinzani PL Musuraca G Tani M 2007J Clin Oncol2007,25,27:1
15Phase I trial of pro tea some inhibitor bortezomib in patients with relapsed or refractory cutaneous T-celllymphoma显示文摘Zinzani PL Musuraca G Tani M 2007J Clin Oncol2007,25,27:1
16Phase Ⅱ trial of proteasome inhibitor bortezomib in patients with re- lapsed or refractory cutaneous T-cell lymphoma显示文摘Zinzani P L Musuraca G Tani M 2007J Clin Oneol2007,25,27:1
17Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma 显示文摘Zinzani PL Musuraca G Tani M 2007J Clin Oneol2007,25,:1
18Phase II trial of protea- some inhibitor bortezomib in patients with relapsed or refractory cutaneous T - cell lymphoma 显示文摘Zinzani PL Musuraca G Tani M 2007J Clin Oncol2007,25,27:1
19Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma显示文摘Derenzini E Musuraca G Fanti S 2008Cancer2008,113,9:1
20Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma 显示文摘Zinzani P L Musuraca G Alinari L 2007Clin Lymphoma Myeloma2007,7,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费